Toxic managers rewarded - Program Manager Merck Employee Review

1.0
May 25, 2025
Recommend
CEO approval
Business Outlook

Pros

Good salary Good flexibility since Covid

Cons

Toxic management. Senior leadership want to be worshiped so they ignore all the concerns raised by the employees and case of bullying by their managers. They lean too much onto office politics than efficiency and performance. Hard work and great performance doesn’t matter at MERCK. This company has a serious issue with toxic management being protected and even rewarded. One manager in particular has driven out multiple talented employees, yet leadership continues to ignore the pattern. Feedback is dismissed, retaliation is real, and opportunities are blocked unless you’re in the manager’s good graces. Concerns have been raised directly and through pulse surveys, but these efforts go nowhere. The surveys are widely seen as performative — a box to check rather than a tool for real change. Employees have learned that raising issues often leads to backlash or being pushed out. Speaking up is a trap. If you come to this company, Double down on any psychotherapy because you will need it. The managers will bully and discriminate against employees with the full protection of HR and senior management. If the employee raises the concerns to senior management or HR, they become the problem and manager with support of senior management will continue their worse. The employee become the target to put down by any mean. The narrative is controlled by those in power.

Explore other reviews about Merck

5.0
Jun 29, 2026
Recommend
CEO approval
Business Outlook

Pros

Benefits and pay are great

Cons

Depends on manager and organization is how your experience and work life balance will be

4.0
Jun 30, 2026
Recommend
CEO approval
Business Outlook

Pros

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Cons

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

See reviews by: Helpful|Rating|Date|All